Skip to content
OpenCapital
Get started

Biote Corp. BTMD Derivative Liabilities (Non-Current)

Derivative Liabilities (Non-Current) at other companies

Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$29.72M+18.9%

Other financials

Income statement

See full
Revenue$44.9M-8.3%
Gross profit$31.0M-14.9%
Operating income$3.2M-67.3%
Net income$2.3M-83.4%
EPS (diluted)$0.06-83.8%

Balance sheet

See full
Cash & equivalents$5.3M-87.2%
Total debt$103.4M-5.5%
Total equity-$56.1M+37.7%
Total assets$89.0M-27.8%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$362.0K-77.8%
Free cash flow$3.5M-26.8%

Valuation

See full
Market cap$57.33M-51.2%
Enterprise value$155.43M-26.5%
P/E3.7×-0.1×
P/S0.3×-0.3×

Profitability

See full
Gross margin70.1%-1.2pp
Operating margin15.4%-0.1pp
Net margin8.3%-2.3pp
FCF margin15.3%-3.2pp

Returns & leverage

See full
Return on equity-21.4%—
Debt / equity9.1×—
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s derivative liabilities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biote Corp.'s derivative liabilities (non-current)?
Biote Corp. (BTMD) reported derivative liabilities (non-current) of $1.96M in Q1 2026.
How has Biote Corp.'s derivative liabilities (non-current) changed year-over-year?
Biote Corp.'s derivative liabilities (non-current) decreased by 69.6% year-over-year, from $6.45M to $1.96M.
What is the long-term trend for Biote Corp.'s derivative liabilities (non-current)?
Over 3 years (2022 to 2025), Biote Corp.'s derivative liabilities (non-current) has grown at a -49.6% compound annual growth rate (CAGR), from $32.11M to $4.11M.
What does derivative liabilities (non-current) mean?
This represents the fair value of derivative financial instruments that are in a liability position and have a maturity date exceeding one year. These instruments are typically used for hedging interest rate, currency, or commodity price risks, but can also include speculative positions. A significant balance indicates potential long-term financial exposure to market volatility and the effectiveness of the company's risk management strategy.